Safety & Allergenicity Study: Confirming Low Allergenicity and High Purity of Blue Eyes Biotech Hydrolyzed Casein

Article Title: Safety & Allergenicity Study: Confirming Low Allergenicity and High Purity of Blue Eyes Biotech Hydrolyzed Casein

Page Description: This safety assessment report provides key data on the low allergenicity, microbiological safety, and chemical contaminant control of Blue Eyes Biotech Hydrolyzed Casein. Results support its safe use in formulas for sensitive populations, high-end infant nutrition, and clean-label products.

Body:

This safety and allergenicity assessment report is compiled by an international laboratory with toxicological testing qualifications, aiming to

systematically verify the safety margins of Hydrolyzed Casein produced by Blue Eyes Biotech CO., Ltd. as a food and nutraceutical ingredient.

For brands targeting infants, individuals with allergies, or those pursuing "clean-label" positioning, the allergenic potential and absolute safety

of raw materials are the primary screening criteria in the supply chain.

One of the core assessment items is the detection of residues of major milk allergens such as β-lactoglobulin and α-casein. Analysis using

sensitive methods like Enzyme-Linked Immunosorbent Assay (ELISA) confirms that the immunoreactivity of key allergenic proteins in the

casein has been significantly reduced to very low levels after processing via Blue Eyes Biotech's proprietary enzymatic hydrolysis process.

This provides crucial scientific support for developing "low-allergenicity" or "suitable for sensitive stomachs" formulated products, broadening

the applicable consumer base.

Regarding chemical safety, testing covers a broader range of potential risk substances. Beyond routine heavy metals, the laboratory also

screened for potentially present pesticide residues, veterinary drug residues (e.g., antibiotics), and harmful substances generated during

processing (e.g., chloropropanols). Test results for all items were either negative or well below the regulatory limits of strict markets like the

EU and the US. Simultaneously, microbiological and pathogen testing, as well as mycotoxin (e.g., aflatoxin M1) testing, all complied with the

highest safety standards.

Furthermore, the report confirms that this Hydrolyzed Casein product is non-GMO and can typically provide gluten-free certification.

This comprehensive safety and compliance profile not only meets basic regulatory requirements but also aligns with the current global

market's high-end demand for transparent, natural, and pure ingredients. Therefore, Blue Eyes Biotech Hydrolyzed Casein serves as a reliable

foundation for developing the next generation of safe, gentle, and trust-backed nutrition and health products.

To obtain the low allergenicity verification report, residue screening certificates, or to discuss compliance documents for specific markets,

please contact us.

Company:Blue Eyes Biotech CO., Ltd

Email:[email protected]

Website:www.blueeyes-bio.com

WhatsApp:+66840769830

Keywords: Hydrolyzed Casein low allergenicity, Allergen testing, Microbiological safety, Pesticide residue screening, Gluten-free certification,

Infant nutrition raw material, Clean-label ingredient, Safety assessment, Blue Eyes Biotech

Facebook Tags:

#LowAllergenicity#AllergenTesting #CleanLabel #InfantNutrition #SafeIngredients #GlutenFree #PureIngredients #BlueEyesBiotech